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dinated with the neuronal differentiation program through
the InR/TOR pathways? Cell growth is potently affected
by the levels of InR or TOR activation in the ommatidial
clusters, but growth per se cannot account for changes
in the timing of differentiation, since induction of other
growth regulators like dMyc or CyclinD/Cdk4 has no
effect on the tempo of ommatidial differentiation. The
InR and TOR pathways have in common the ability to
link cell growth to external conditions like nutrition. The
growth and maintenance of a long axonal process could
constitute a challenging cellular event that might be
particularly sensitive to the nutritional status. This could
explain the requirement for a specific checkpoint mech-
anism allowing a tight coupling between nutrition and
differentiation in neurons. Another case of connection
between insulin functions and neuronal differentiation
was reported recently, in which InR appears to regulate
axon guidance and targeting in the fly visual system
through direct coupling of its C-terminal tail with the
adaptor protein Dock/Nck (Song et al., 2003). This work
now opens the route for studying the general orchestra-
tion of cell differentiation mechanisms by extrinsic/envi-
ronmental parameters.
Figure 1. TOR and InR Pathways Coordinate Neuronal Differentia-
tion with Nutritional Information
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stream of the major effector of photoreceptor differenti-
ation, the EGFR/MAPK pathway. Such a precocious dif-
ferentiation can also be observed in other neuronal cells,
like those forming the mechanosensory organs in the
leg imaginal disc but not in epithelial cells of the wing
disc, which differentiate into hair-like structures. This PGC-1: Turbocharging
suggests that the biological significance of this temporal Mitochondria
control might be restricted to neuronal cells.
Important questions remain. What mediates this regu-
lation? In one proposed scenario, accumulation of an
unknown proneural factor could rely on translation con- PGC-1 plays essential and diverse functions in the
control of metabolism ranging from mitochondrial bio-trol exerted by TOR and InR pathways and become
limiting in situations where growth is impeded. No candi- genesis and respiration to hepatic gluconeogenesis
and muscle fiber-type switching. In a paper by Lin etdate factor is provided in the present paper, but the fact
that alterations in the timing of differentiation always al. (2004, this issue of Cell), the characterization of
PGC-1/ mice illustrates these pleiotropic functionsoccur at the appropriate location might indeed suggest
a mechanism based on the controlled translation of pre- and reveals an unexpected role for PGC-1 in the
brain.existing transcripts. What developmental cues are coor-
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Peroxisome proliferator-activated receptor  (PPAR) (ATP) deficit is further underscored by the activation of
AMP-activated protein kinase subsequent to the re-coactivator 1 (PGC-1) is the founding member of a
family of transcriptional coactivators that also includes duced cellular ATP/AMP ratio. Paradoxically, whereas
in man a decrease in PGC-1, OXPHOS genes, andPGC-1 (also called PERC) and PGC-1-related coactiva-
tor (reviewed in Puigserver and Spiegelman, 2003). PGC- impaired mitochondrial activity in muscle has been
linked with obesity, insulin resistance and predisposition1 is expressed in heart, kidney, brown adipose tis-
sue (BAT), and brain and was originally described as a to diabetes (Petersen et al., 2004 and references
therein), PGC-1/ mice are lean and resistant to diet-cold-inducible coactivator controlling adaptive thermo-
genesis in BAT and skeletal muscle by stimulating mito- induced obesity reflective of a substantial increase in
energy expenditure. How can we explain this?chondrial biogenesis and oxidative metabolism. Fasting
induces hepatic PGC-1 expression thereby increasing Energy expenditure is accounted for by adaptive ther-
mogenesis and physical activity. In the wake of the de-gluconeogenesis, whereas in skeletal and cardiac mus-
cle exercise increases PGC-1, mitochondrial biogene- creased mitochondrial function and adaptive thermo-
genesis in PGC-1/ mice, the most likely culprit tosis, and respiration. Thus, PGC-1 expression seems
finely tuned to reflect the cellular energy needs, with explain the increased energy expenditure is an in-
creased physical activity. In addition to being hyperac-conditions of increased energy demands, such as cold,
physical activity, or fasting inducing its expression. tive, PGC-1/ mice also have behavioral abnormali-
ties, stimulus-induced myoclonus, exaggerated startlePGC-1 accomplishes these diverse functions through
activating nuclear receptors like the PPARs, thyroid hor- responses, dystonic posturing, frequent limb clasping,
and showed spongiform lesions in striatum and brainmone receptors (TR), estrogen-related receptors (ERR),
glucocorticoid receptor (GR) and hepatocyte nuclear stem. Both these clinical and pathological findings are
reminiscent of neurodegenerative disorders of move-factor (HNF) 4, and other transcription factors, includ-
ing nuclear respiratory factors (NRF) and FOXO1 (Figure ment, most notably of Huntington’s disease (HD), an
autosomal dominant degenerative brain disorder, char-1). PGC-1 is dependent on other coregulators like the
steroid receptor coactivator-1 (SRC-1) for its activity acterized by choreiform movements and dementia, that
begins in adulthood and neuropathologically strikes the(Puigserver et al., 1999; Picard et al., 2002).
Lin and coworkers now report in Cell the phenotypic striatum. HD is the consequence of an expansion of
CAG trinucleotide repeats occurring in the open readinganalysis of PGC-1/ mice, which illustrates the diver-
sity of PGC-1 physiology (Lin et al., 2004). The high frame of huntingtin, now encoding a protein with an
expanded polyglutamine (polyQ) tract. Interestingly, ho-postnatal mortality in PGC-1/ mice already under-
scores its importance for survival. Future studies are mozygous and heterozygous HD patients have similar
phenotypes, suggesting that the gain of function of hun-required to determine the cause of excessive neonatal
death. Interestingly, gluconeogenesis is constitutively tingtin is toxic to neurons. The leading hypothesis to
explain the HD phenotype is that the expanded polyQactivated and uncoupled of nutritional status in surviving
PGC-1/ mice. This constitutive activation of gluco- tract in huntingtin interferes with other cellular pro-
cesses, such as mitochondrial function. Mitochondrialneogenesis was subsequent to the induction of gluco-
neogenic genes by the elevated levels of C/EBP. These dysfunction has since a long-time been linked with neu-
rodegenerative diseases, a finding again highlighted byin vivo data are in apparent conflict with the predictions
made from their in vitro studies and the defective gluco- the decreased expression of mitochondrial genes in
PGC-1/ mice. Other coregulators such as the CREBneogenesis in isolated PGC-1/ hepatocytes (Lin et
al., 2004). Furthermore, acute adenoviral-mediated binding protein (CBP), the mammalian Sir2 homolog
SIRT1, and TAFII130 have been linked with neurobehav-downmodulation of hepatic PGC-1 with small inter-
fering RNA (RNAi) was reported to decrease gluconeo- ioral abnormalities and neurodegeneration (Araki et al.,
2004). In view of this, the role of PGC-1 and othergenesis leading to fasting hypoglycemia (Koo et al., 2004).
The studies in PGC-1/ hepatocytes and with adenovi- coregulators with impact on energy homeostasis should
be carefully explored in neurodegenerative diseases.rus-mediated PGC-1 RNAi address, however, acute
hepatic depletion of PGC-1, which is in contrast to the From a therapeutic perspective, PGC-1/ mice fur-
ther validate the notion that stimulation of mitochondrialstudies in animals with a genetic PGC-1 deficiency in
all tissues. In such animals, both chronic compensation, activity could be useful in the context of diseases such
as obesity and associated metabolic disorders. It is in-as well as signals of nonhepatic PGC-1-deficient tis-
sues, are confounders. Temporally and spatially con- teresting to note that an increase in physical activity
and dietary restriction, the cornerstone of the therapytrolled PGC-1mutants will be useful to clarify this issue.
PGC-1/ mice also have reduced mitochondrial of obesity and metabolic syndrome, are both inducing
PGC-1 activity. The molecular mechanism throughfunction and defects in oxidative phosphorylation
(OXPHOS). This is not only reflected by abnormal gluco- which exercise and dietary restriction induce PGC-1
activity are not known in detail, however, several signal-neogenesis, which is dependent on ATP generated by
OXPHOS, but also by impaired cold resistance. Adaptive ing pathways are being proposed. These include protein
kinase A subsequent to activation of G protein-coupledthermogenesis in rodents is mainly a function of BAT in
which mitochondrial oxidation is partially uncoupled of receptors such as the glucagon and 3-adrenergic re-
ceptor, calcium/calmodulin-dependent protein kinaseenergy production through the action of uncoupling pro-
tein 1 (UCP-1). UCP-1 expression is reduced in PGC- IV and calcineurin A, p38 mitogen-activated protein ki-
nase (reviewed in Puigserver and Spiegelman, 2003;1/ BAT. Furthermore, PGC-1/ mice have severe
defects in expression of genes involved in OXPHOS and Kelly and Scarpulla, 2004), S6 kinase 1, an effector of
mammalian target of rapamycin, acting in an ancientmitochondrial function in muscle. This muscle energy
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Figure 1. Schematic Representation of the Different Functions of PGC-1 in Its Target Tissues
See text for explanation.
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